Treatment with combination of PEG IFN α-2B and ribavirin suppresses viral replication in liver transplantation recipients with recurrent HCV hepatitis

被引：0
|
作者：
Khatib, MA [1 ]
Arenas, JI [1 ]
Carey, E [1 ]
Moss, A [1 ]
Mulligan, D [1 ]
Ortiz, L [1 ]
Hansen, K [1 ]
Harrison, ME [1 ]
Douglas, D [1 ]
Balan, V [1 ]
Rakela, J [1 ]
Vargas, HE [1 ]
机构：
[1] Mayo Clin Scottsdale, Phoenix, AZ USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
64
引用
收藏
页码：182A / 182A
页数：1
相关论文
共 50 条
  • [21] HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin
    Moreno, A
    Bárcena, R
    García-Garzón, S
    Muriel, A
    Quereda, C
    Moreno, L
    Mateos, ML
    Fortún, J
    Martín-Dávila, P
    García, M
    Blesa, C
    Otón, E
    Moreno, A
    Moreno, S
    JOURNAL OF HEPATOLOGY, 2005, 43 (05) : 783 - 790
  • [22] Pegylated interferon alpha 2b (PEG IFN) plus ribavirin (R) for treatment of chronic hepatitis C: Optimization of ribavirin dose
    Manns, M
    Mc Hutchison, JG
    Gordorn, S
    Rustgi, V
    Lee, MV
    Ling, ML
    Cohard, M
    Albrecht, JK
    JOURNAL OF HEPATOLOGY, 2001, 34 : 236 - 236
  • [23] Autoimmune thrombocytopenia induced by PEG-IFN-α2b plus ribavirin in hepatitis C
    Sagir, A
    Wettstein, M
    Heintges, T
    Häussinger, D
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 562 - 563
  • [24] Is weekly PEG IFN alpha 2B with ribavirin therapy better than daily IFN alpha 2B with ribavirin therapy?
    Ahmed, U
    Ahmed, S
    Wright, H
    Nour, B
    Gurakar, A
    Schade, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S104 - S104
  • [25] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    HEPATOLOGY, 2002, 36 (04) : 183A - 183A
  • [26] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [27] Differing immune effects of PEG-IFN-alpha 2b and IFN-alpha 2b combined with ribavirin for chronic hepatitis C
    Ishii, K
    Sumino, Y
    Higami, K
    Fujita, Y
    Shinohara, M
    Ikehara, T
    Shinohara, M
    Matsumaru, K
    Nagai, H
    Watanabe, M
    Miki, K
    HEPATOLOGY, 2005, 42 (04) : 677A - 678A
  • [28] PROSPECTIVE RANDOMIZED TRIAL COMPARING PEGIFNALPHA 2A AND PEGIFN ALPHA 2B WITH RIBAVIRIN IN HCV-LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C
    Aguilera, V.
    Prieto, M.
    Rubin, A.
    Risalde, B.
    Ortiz Canto, C.
    Berenguer, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S184 - S184
  • [29] The Effect and Safety of the Treatment of Recurrent Hepatitis C Infection After Orthotopic Liver Transplantation With Pegylated Interferon α2b and Ribavirin
    Perrakis, A.
    Yedibela, S.
    Schuhmann, S.
    Croner, R.
    Schellerer, V.
    Demir, R.
    Hohenberger, W.
    Mueller, V.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) : 3824 - 3828
  • [30] IFN-ALPHA 2B THERAPY OF VIRAL-HEPATITIS FOLLOWING LIVER-TRANSPLANTATION
    WRIGHT, HI
    GAVALER, JS
    TODO, S
    FUNG, J
    STARZL, TE
    VANTHIEL, DH
    HEPATOLOGY, 1991, 14 (04) : A71 - A71
12345